Showing results (591-600 of 1,255) with videos related to
Sort By:
Pageof 126
Birth Defects Research. Part A, Clinical and Molecular Teratology|June 17, 2014
Midline craniofacial malformations with a lipomatous cephalocele are associated with insufficient closure of the neural tube in the tuft mouseKeith S K Fong, Dana A T Adachi, Shaun B Chang, et al.Birth Defects Research. Part A, Clinical and Molecular Teratology|August 7, 2012
Bone morphogenetic proteins regulate hinge point formation during neural tube closure by dynamic modulation of apicobasal polarityDae Seok Eom, Smita Amarnath, Jennifer L Fogel, et al.Birth Defects Research. Part A, Clinical and Molecular Teratology|September 5, 2012
Neural tube defects on the Texas-Mexico border: what we've learned in the 20 years since the Brownsville clusterLucina Suarez, Marilyn Felkner, Jean D Brender, et al.Birth Defects Research. Part A, Clinical and Molecular Teratology|September 5, 2012
Epithelial fusion during neural tube morphogenesisYun-Jin Pai, N L Abdullah, S W Mohd-Zin, et al.Birth Defects Research. Part A, Clinical and Molecular Teratology|June 26, 2012
Public preferences for counseling regarding antidepressant use during pregnancy: a discrete choice experimentRebecca L Hancock-Howard, Wendy J Ungar, Deborah Marshall, et al.Birth Defects Research. Part A, Clinical and Molecular Teratology|August 21, 2012
Evaluation of ICD-9-CM codes for craniofacial microsomiaDaniela V Luquetti, Babette S Saltzman, Daniela Vivaldi, et al.Birth Defects Research. Part A, Clinical and Molecular Teratology|August 2, 2012
Cancer chemotherapeutic agents as human teratogensBrady P Selig, James R Furr, Ryan W Huey, et al.Birth Defects Research. Part A, Clinical and Molecular Teratology|July 19, 2012
Maternal occupational exposure to polycyclic aromatic hydrocarbons and risk of neural tube defect-affected pregnanciesPeter H Langlois, Adrienne T Hoyt, Philip J Lupo, et al.Birth Defects Research. Part A, Clinical and Molecular Teratology|July 19, 2012
Is there an embryopathy associated with first-trimester exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists? A critical review of the evidenceJanine E PolifkaBirth Defects Research. Part A, Clinical and Molecular Teratology|July 21, 2012
Mutations in Lyar and p53 are synergistically lethal in female miceGuan Wang, Christopher M Fulkerson, Reem Malek, et al.Pageof 126